United States Molecular Diagnostics and Blood Donor Screening Market Report 2016 - Forecasted to 2022

Nov 16, 2015, 08:10 ET from Research and Markets

DUBLIN, Nov. 16, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/462lq2/us_market_for) has announced the addition of the "US Market for Molecular Diagnostics and Blood Donor Screening - 2016 (Forecasted to 2022)" report to their offering.

The MDx market includes analytical systems and assays used for DNA (and RNA) extraction, amplification and detection. Systems can range from low throughput instruments such as thermal cyclers to high throughput automated systems. They may run on different technologies such as polymerase chain reaction (PCR), transcription mediated amplification (TMA) or gel electrophoresis.

Tests may be used for identifying disease, for monitoring disease progression and effects of treatment or for predicting predisposition of individuals to various diseases. Revenues associated with companion diagnostic tests for therapeutic drugs or testing done using technologies such as Fluorescence In Situ Hybridization (FISH) or Next Generation Sequencing (NGS) are not included in this report.

Molecular diagnostics, once confined to large labs with highly trained laboratorians, is rapidly being adopted by smaller hospitals and independent labs with less skilled labor due to the following key factors: availability of automated systems capable of performing multiple functions and running multiple assays on a single platform, decreasing test prices owing to the entry of many smaller competitors, high specificity and sensitivity of molecular assays compared to other traditional testing methods (such as microbiology or immunoassays), and favorable FDA guidelines requiring new drug therapies to be tested for their efficacy on particular patient groups through associated companion diagnostic tests.

All these factors will enable molecular diagnostics to continue its dominance in the U.S. IVD market in the future. While Roche Diagnostics was the clear market leader for 2015 in the Molecular Diagnostics Assay Kit Market, they still were far behind Grifols USA within the Molecular Blood Donor Screening Market.

More detailed information on these companies as well as Hologic, Myriad Genetics, Genomic Health, Cephied, Qiagen, Becton Dickinson, Abbott Diagnostics and many more are found in this 2 segment report.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Molecular Diagnostics Market

4. Molecular Blood Donor Screening Market

5. Abbreviations

Companies Mentioned

- Abbott Diagnostics
- Becton Dickinson
- Cephied, Qiagen
- Genomic Health
- Grifols USA
- Hologic
- Myriad Genetics
- Roche Diagnostics

For more information visit http://www.researchandmarkets.com/research/462lq2/us_market_for

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets